Clinical Trial Update: To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion). [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating generic diclofenac sodium topical gel 1% for knee osteoarthritis has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• diclofenac sodium topical gel, 1% (diclofenac sodium topical gel, 1%)

Snippet

Sponsor: Glenmark Pharmaceuticals Ltd. India | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-06-28